Factors associated with long-term pessary use by Winn, Heather M et al.
Proceedings in Obstetrics and Gynecology, 2020;9(3):15 
 
 
1Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa Hospitals and 
Clinics, Iowa City, IA, 52242 
2Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242 
3Department of Obstetrics and Gynecology, Division of Urogynecology and Reconstructive Pelvic Surgery, 
University of Iowa Hospitals and Clinics, 500 Hawkins Drive, Iowa City, Iowa, 52242 
Please cite this abstract as: Winn HM, Morcuende I, Genadry RR, Kowalski JT, Bradley CS. Factors associated with 
long term pessary use. Proc Obstet Gynecol. 2020;9(3):Article 15 [ 2 p.]. Available from: http://ir.uiowa.edu/pog/ Free 
full text article.  
Corresponding author: Heather M. Winn, Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins 
Drive, Iowa City, IA 52242, heather-winn@uiowa.edu  
Copyright: © 2020 Winn, et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
author and source are credited.  
 1 
 
 
 
Factors associated with long-term pessary use 
Heather M. Winn, MD,1 Irene Morcuende,2 Rene R. Genadry, MD,3 Joseph T. Kowalski, 
MD,3 Catherine S. Bradley, MD., MSCE3 
Keywords: pessary, pelvic organ prolapse, long-term pessary use
Objective 
Vaginal pessary is a well-established 
pelvic organ prolapse (POP) treatment, 
but little evidence about long-term use is 
available. Our aim was to report the 
duration of use and investigate predictors 
of long-term pessary use for POP. We 
hypothesized that younger, healthier 
women and women who experienced 
complications would have shorter 
duration of use.  
Methods 
This was a secondary analysis 
performed in a retrospective cohort study 
of patients undergoing pessary treatment 
for POP. Patients were identified using 
billing codes. Those successfully fitted 
with a POP pessary from 2008-2016 and 
who continued use for at least 3 months 
were eligible. Data were abstracted from 
the electronic medical record. Women 
with pessary use for ≥1 and for ≥3 years 
were compared to those with <1-year 
use. Groups were compared using chi-
square, Fisher’s exact, Wilcoxon rank 
sum and student t-tests.  
Results 
The cohort included 268 patients, with 
mean age 65.8±11.9 years. 94% were 
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white, 88% post-menopausal, 39% 
sexually active. The <1-year group were 
younger (p=0.03 vs. ≥1 year; p=0.19 ≥ 3 
year) and had more pulmonary disease 
(p<0.01 for both). Other baseline medical 
co-morbidities did not differ between 
short and long-term pessary users 
(p>0.05 for all). During follow-up, vaginal 
irritation, bleeding or pain were more 
often reported in those with <1 year 
compared to ≥1-year use (p=0.03, 0.04, 
0.02). 78 patients reported reasons for 
discontinuation, most commonly cited 
were increase in urinary incontinence 
(n=28) and vaginal pain (n=18).  
Conclusions 
Few baseline factors were associated 
with long vs. short-term pessary use. 
Those with <1-year use were younger, 
but the age difference was small. 
Baseline pulmonary disease strongly 
correlated with shorter pessary use. 
Adverse symptoms related to the 
pessary (irritation, bleeding and pain) 
may be drivers for pessary 
discontinuation in the first year. 
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